Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR52B4 Inhibitors

The olfactory receptor OR52B4 is part of a family of genes involved in the detection of airborne molecules and contributes to the complexity of scent perception. These receptors are predominantly expressed in the sensory neurons of the olfactory epithelium and are responsible for the initial step in the olfactory signal transduction pathway, which is critical for the sense of smell. The expression of OR52B4, like other olfactory receptors, is tightly controlled at the transcriptional level, and this regulation is a sophisticated process influenced by a variety of intracellular and extracellular factors. Environmental cues, endogenous hormones, and even the metabolic state of the organism can lead to changes in the gene expression of OR52B4. Chemical compounds can play a role in this regulation by interacting with the intricate network of cellular pathways that govern gene expression. A diverse range of chemicals can potentially inhibit the expression of OR52B4 by targeting different stages of the gene expression process. For instance, epigenetic modifiers like 5-Azacytidine and Trichostatin A can alter the chromatin structure at the OR52B4 gene locus, potentially leading to a reduction in gene transcription. Hormonally active compounds such as Diethylstilbestrol and Vinclozolin might bind to specific hormone receptors and interfere with the hormonal control of OR52B4 expression, whereas chemicals like Methimazole and Ketoconazole that influence hormone synthesis could also indirectly downregulate OR52B4. Environmental toxins such as Dioxin and heavy metals like Lead (II) acetate may decrease OR52B4 expression by interfering with transcriptional activators. Even lifestyle-related substances such as Ethanol could lead to a broad suppression of gene activity, including that of olfactory receptors. It is important to understand that the interaction between these chemicals and the OR52B4 receptor is complex and subject to individual variability, as well as environmental factors. Research into the specific inhibitory mechanisms of these chemicals on OR52B4 expression continues, which contributes to our broader understanding of how gene expression can be modulated by external compounds.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This DNA methyltransferase inhibitor could induce demethylation at the OR52B4 gene promoter, leading to a downregulation of its transcription.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

As an HDAC inhibitor, Trichostatin A could promote histone acetylation at the OR52B4 locus, resulting in a compact chromatin state and decreased transcriptional activity of the OR52B4 gene.

Vinclozolin

50471-44-8sc-251425
250 mg
$23.00
1
(1)

By antagonizing androgen receptors, Vinclozolin might reduce the expression of OR52B4 if its expression is androgen-responsive.

Diethylstilbestrol

56-53-1sc-204720
sc-204720A
sc-204720B
sc-204720C
sc-204720D
1 g
5 g
25 g
50 g
100 g
$70.00
$281.00
$536.00
$1076.00
$2142.00
3
(1)

This synthetic estrogen could bind estrogen receptors and alter the transcriptional machinery, leading to a decrease in OR52B4 gene expression within estrogen-responsive regulatory contexts.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic acid may engage retinoic acid receptors that bind to retinoic acid response elements near the OR52B4 gene, leading to a repression of its transcriptional initiation.

Methimazole

60-56-0sc-205747
sc-205747A
10 g
25 g
$69.00
$110.00
4
(0)

By inhibiting thyroid hormone synthesis, Methimazole could decrease the expression of OR52B4 if the receptor′s expression is thyroid hormone-dependent.

Ketoconazole

65277-42-1sc-200496
sc-200496A
50 mg
500 mg
$62.00
$260.00
21
(1)

Ketoconazole can suppress steroid biosynthesis, which could lead to a reduction in OR52B4 expression levels by altering hormonal balances within the body that control the transcription of this receptor.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Sodium Butyrate may lead to hyperacetylation of histones at the OR52B4 gene locus, which could suppress transcription and result in decreased OR52B4 mRNA levels.

Bisphenol A

80-05-7sc-391751
sc-391751A
100 mg
10 g
$300.00
$490.00
5
(0)

As a compound with estrogenic activity, Bisphenol A could disrupt the normal hormonal control mechanisms and downregulate OR52B4 expression by competing with natural hormones that would otherwise modulate OR52B4 expression levels.

Lead(II) Acetate

301-04-2sc-507473
5 g
$83.00
(0)

Lead exposure can result in the perturbation of various cellular signaling pathways, potentially leading to a decrease in OR52B4 expression by interfering with transcription factors or coactivators necessary for OR52B4 gene transcription.